Skip to main content

Satellite Electric Propulsion Market Growth Insights and Forecasts to 2032


Satellite electric propulsion has gained significant importance over three years (2019-2021). An increase in the requirement of satellites around the globe from various end users, such as defense and government, and commercial, has generated the demand for electric propulsion during the forecast period. The industry is currently focusing on developing high-efficient and low-weight satellites that can be used for several years. The research study is based on extensive primary interviews (in-house industry players, market leaders, and experts) and secondary research (a host of paid and unpaid databases), along with analytical tools to predict the forecast analysis for the study period. With the help of these, the satellite electric propulsion study provides a broader perspective of the industry.

Read Report Overview: https://bisresearch.com/industry-report/satellite-electric-propulsion-market.html

In the current market scenario, there are diverse and mature electric propulsion systems available to propel the satellite and spacecraft in various Earth’s orbits and deep space missions. The hall-effect thrusters (HETs) and gridded-ion engines (GIE) are one of the prominent electric propulsion technologies available in the current market and are mostly used in satellites. Some of the major satellite constellation operators, such as SpaceX and OneWeb, are using HETs for their satellites owing to thrust and high specific impulse (Isp), making them suitable for longer-duration mission applications. Additionally, the national space agencies are integrating more electric propulsion for their upcoming deep space missions. For instance, NASA uses electric propulsion for power and propulsion element (PPE) in its Lunar Gateway mission, which is planned to be launched by 2024.

Furthermore, the small satellite constellations are driving the growth of electric propulsion as various satellite operators are deploying small satellites in large quantities to the low Earth orbit (LEO) for providing communication, Earth observation, and navigation services, among others. As the constellation size increases, the cost of satellite development upsurges with using a heavier chemical propulsion system. So, the market is experiencing a shift toward the deployment of electric propulsion for station keeping, orbital maneuvers, and de-orbiting. Also, the electric propulsion system takes less space while maintaining its efficiency and providing extra space to carry more payloads. 

Additionally, the geostationary Earth orbit (GEO) segment has also witnessed the adoption of more electric propulsion for orbital maneuvers and orbit raising. Traditionally, chemical propulsion is used for orbit raising as it produces high thrust and can maneuver the satellite through geostationary transfer orbits (GTO) in approximately one week, but the propellant takes up half of the satellite’s wet mass. 

Request for the Sample Report at: https://bisresearch.com/requestsample?id=1358&type=download

During the initial years of the development of space technologies, the primary focus of companies had been on developing heavy and large-sized satellites. However, in recent times, the space industry has witnessed a number of technological advancements which have created substantial demand for small-size satellites for low Earth orbit (LEO) as well as cost-effective launch solutions.

The low Earth orbit (LEO) is now attracting constellation companies and becoming crowded. Constellation operators are attracting investors in the space industry, and it is creating the demand for various satellite components needed to efficiently operate these satellites in LEO. There are many reasons for placing small satellite constellations in LEO, as they are lighter and have low launch costs.

Comments

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @  https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023.  The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...

Neoantigens Vaccines Can Bridge the Treatment Gap by Training the Immune System to Recognize Tumor Cells

As per BIS Research analysis, the neoantigen cancer vaccine market is projected to reach $1826.1 million by 2030 from $227.1 million in 2023, at a CAGR of 34.69%. Growth in this market is expected to be driven by the ever-rising patient pool of different cancers and significant investment in research for development for cancer neoantigen vaccines to fill in the current treatment gaps. However, there are significant challenges that are restraining the market growth. These challenges include the high cost of therapy (personalized cancer vaccines), manufacturing complications, and lack of therapeutic biomarkers and assays. The market is still at the nascent phase with more than two-thirds of the neovaccines in the early stages of development. However, few neovaccines companies such as OSE Immunotherapeutics, Immunovative Therapeutics, Medigene, and Roche have positioned themselves to launch their neovaccines in the market within the upcoming years. That being said, the neovacc...